 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for CYP26A1 |
 Gene summary |
| Basic gene information | Gene symbol | CYP26A1 |
| Gene name | cytochrome P450, family 26, subfamily A, polypeptide 1 | |
| Synonyms | CP26|CYP26|P450RAI|P450RAI1 | |
| Cytomap | UCSC genome browser: 10q23-q24 | |
| Type of gene | protein-coding | |
| RefGenes | NM_000783.3, NM_057157.2, | |
| Description | P450, retinoic acid-inactivating, 1cytochrome P450 26A1cytochrome P450 retinoic acid-inactivating 1cytochrome P450, subfamily XXVIA, polypeptide 1cytochrome P450RAIhP450RAIretinoic acid 4-hydroxylaseretinoic acid-metabolizing cytochrome | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 602239 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000095596 | ||
| HPRD : 03759 | ||
| Vega : OTTHUMG00000018765 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_CYP26A1 | |
| BioGPS: 1592 | ||
| Pathway | NCI Pathway Interaction Database: CYP26A1 | |
| KEGG: CYP26A1 | ||
| REACTOME: CYP26A1 | ||
| Pathway Commons: CYP26A1 | ||
| Context | iHOP: CYP26A1 | |
| ligand binding site mutation search in PubMed: CYP26A1 | ||
| UCL Cancer Institute: CYP26A1 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | HPA,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Liver | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHC | |
| Reference showing the relevant tissue of CYP26A1 | ||
| Description by TissGene annotations | ||
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID | GO:0034653 | retinoic acid catabolic process | 10823918 | GO:0034653 | retinoic acid catabolic process | 10823918 |
| Top |
| TissGeneExp for CYP26A1 |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
 |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| LUSC | 1.973479568 | -1.681806707 | 3.655286275 | 3.02E-09 | 9.96E-09 |
| LIHC | 0.24174894 | 5.50764094 | -5.265892 | 1.22E-21 | 8.74E-20 |
| THCA | -1.261028043 | -2.333970416 | 1.072942373 | 1.07E-05 | 3.46E-05 |
| LUAD | -0.671713198 | -1.946559749 | 1.274846552 | 0.000468 | 0.001071147 |
| STAD | -1.738185935 | -2.771698435 | 1.0335125 | 0.000138 | 0.001024297 |
| Top |
| TissGene-miRNA for CYP26A1 |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for CYP26A1 |
| TissGeneSNV for CYP26A1 |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.R64W | STAD | 2 |
| p.V322I | LAML | 1 |
| p.G76S | KIRP | 1 |
| p.D134N | HNSC | 1 |
| p.Y355C | PAAD | 1 |
| p.P424S | UCEC | 1 |
| p.R306Q | UCS | 1 |
| p.Q255R | HNSC | 1 |
| p.H425Y | SKCM | 1 |
| p.C12R | LUAD | 1 |
| p.G52E | BLCA | 1 |
| p.V142L | LUAD | 1 |
| p.G232R | UCEC | 1 |
| p.L125Q | HNSC | 1 |
| p.A24V | STAD | 1 |
| p.G204R | STAD | 1 |
| p.E296K | CESC | 1 |
| p.R375Q | UCS | 1 |
| p.W465R | BRCA | 1 |
| p.L459P | STAD | 1 |
| p.E78K | BLCA | 1 |
| p.E193K | LUAD | 1 |
| p.G16R | COAD | 1 |
| p.R106W | STAD | 1 |
| p.R327* | UCEC | 1 |
| p.K338N | BRCA | 1 |
| p.A460V | UCEC | 1 |
| p.E446* | UCEC | 1 |
| p.G401R | SKCM | 1 |
| p.K331N | UCEC | 1 |
| p.R90L | KIRP | 1 |
| p.G7S | KIRP | 1 |
| p.L194Q | HNSC | 1 |
| p.I287L | COAD | 1 |
| p.Q324R | HNSC | 1 |
| p.T12M | COAD | 1 |
| p.A176T | PRAD | 1 |
| p.L168R | UCEC | 1 |
| p.Y286C | PAAD | 1 |
| p.E227K | SKCM | 1 |
| p.L164P | LUSC | 1 |
| p.T473I | STAD | 1 |
| p.R349Q | BLCA | 1 |
| p.G135R | STAD | 1 |
| p.R418* | UCEC | 1 |
| p.R418Q | BLCA | 1 |
| p.G123D | STAD | 1 |
| p.A460T | STAD | 1 |
| p.T387A | LUAD | 1 |
| p.R98W | STAD | 1 |
| p.E293Q | BLCA | 1 |
| p.R191H | STAD | 1 |
| p.S441T | OV | 1 |
| p.F222L | UCEC | 1 |
| p.R219H | STAD | 1 |
| p.F153V | COAD | 1 |
| p.W279R | UCEC | 1 |
| p.A358V | SKCM | 1 |
| p.A170E | TGCT | 1 |
| p.R365Q | UCEC | 1 |
| p.E362Q | BLCA | 1 |
| p.I31M | BLCA | 1 |
| p.E147K | BLCA | 1 |
| Top |
| TissGeneCNV for CYP26A1 |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for CYP26A1 |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Chimerdb3.0 | ChiTaRs | NA | BE350062 | CYP26A1-DGCR2 | chr10:94833799 | chr22:19029387 | |
| Chimerdb3.0 | FusionScan | ESCA | TCGA-IG-A97I-01A | EXOC6-CYP26A1 | In-Frame | chr10:94708136 | chr10:94834064 |
| TCGAfusionPortal | PRADA | BRCA | TCGA-E2-A576-01A | NRBF2-CYP26A1 | In-frame | Chr10:64893260 | Chr10:94835583 |
| Top |
| TissGeneNet for CYP26A1 |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for CYP26A1 |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
 |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
 |
| Top |
| TissGeneClin for CYP26A1 |
| TissGeneDrug for CYP26A1 |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for CYP26A1 |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0023487 | Acute Promyelocytic Leukemia | 4 | BeFree |
| umls:C0006142 | Malignant neoplasm of breast | 3 | BeFree |
| umls:C0042842 | Vitamin A Deficiency | 3 | BeFree,GAD |
| umls:C0678222 | Breast Carcinoma | 3 | BeFree |
| umls:C1168401 | Squamous cell carcinoma of the head and neck | 3 | BeFree |
| umls:C0010278 | Craniosynostosis | 2 | BeFree |
| umls:C0080178 | Spina Bifida | 2 | BeFree,LHGDN |
| umls:C0001418 | Adenocarcinoma | 1 | BeFree,CTD_human |
| umls:C0001430 | Adenoma | 1 | BeFree |
| umls:C0002395 | Alzheimer's Disease | 1 | GAD |
| umls:C0003850 | Arteriosclerosis | 1 | BeFree |
| umls:C0004153 | Atherosclerosis | 1 | BeFree |
| umls:C0004763 | Barrett Esophagus | 1 | CTD_human |
| umls:C0009375 | Colonic Neoplasms | 1 | BeFree,CTD_human |
| umls:C0014175 | Endometriosis | 1 | CTD_human |
| umls:C0014859 | Esophageal Neoplasms | 1 | CTD_human |
| umls:C0017612 | Glaucoma, Open-Angle | 1 | GAD |
| umls:C0022658 | Kidney Diseases | 1 | GAD |
| umls:C0023418 | leukemia | 1 | BeFree |
| umls:C0024198 | Lyme Disease | 1 | BeFree |
| umls:C0027794 | Neural Tube Defects | 1 | GAD |
| umls:C0027819 | Neuroblastoma | 1 | BeFree |
| umls:C0032580 | Adenomatous Polyposis Coli | 1 | BeFree,CTD_human |
| umls:C0036341 | Schizophrenia | 1 | GAD |
| umls:C0038013 | Ankylosing spondylitis | 1 | BeFree |
| umls:C0263641 | Epithelial hyperplasia of skin | 1 | BeFree |
| umls:C0497327 | Dementia | 1 | GAD |
| umls:C0596263 | Carcinogenesis | 1 | BeFree |
| umls:C0684249 | Carcinoma of lung | 1 | BeFree |
| umls:C0700095 | Central neuroblastoma | 1 | BeFree |
| umls:C1561546 | Alkaline Phosphatase Adverse Event | 1 | GAD |
| umls:C1860042 | Antley-Bixler Syndrome with Disordered Steroidogenesis | 1 | BeFree |
| umls:C2745900 | Promyelocytic leukemia | 1 | BeFree |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |